Cognitive abnormalities in cirrhosis

Size: px
Start display at page:

Download "Cognitive abnormalities in cirrhosis"

Transcription

1 AISF Young Investigator Lecture Cognitive abnormalities in cirrhosis Sara Montagnese

2 Disclosures I have received lecture fees from Merz Pharmaceuticals GmbH and Norgine The University of Padova has received research funding for me and my team from Merz Pharmaceuticals GmbH

3 Vignette Patient with cirrhosis Referred to our clinic for cognitive disorders in medicine HE or pre-transplant work-up

4

5

6 Neuropsychiatric Evaluation Structured interview Clinical evaluation/neurological examination Electroencephalogram (EEG) Set of neuropsychological tests (including PHES)

7 Weissenborn et al., J Hepatol 2001 Amodio et al., J Hepatol 2008

8 Neuropsychiatric Evaluation Structured interview Clinical evaluation/neurological examination Electroencephalogram (EEG) Set of neuropsychological tests (including PHES) Critical Flicker Frequency (CFF)

9 Neuropsychiatric Evaluation Structured interview Clinical evaluation/neurological examination Electroencephalogram (EEG) Set of neuropsychological tests (including PHES) Critical Flicker Frequency (CFF) Set of laboratory tests Repeat after treatment / brain imaging

10 Vignette - 26/05/ year old male Alcohol-related cirrhosis (off 3 yrs) Child B, MELD 17 No history of overt HE Fasting, venous ammonia 41 µmol/l (<35)

11 Vignette - 26/05/2014 Clinically normal MMSE 23/30 (memory) PHES=-10 (>-4) Computer tests x CFF 38 (> 39 Hz)

12 Vignette - 26/05/2014

13 Vignette - 26/05/2014 Clinically normal MMSE 23/30 (memory) PHES= -10 Computer tests x CFF 38

14 Vignette - 26/05/2014..The features of the neuropsychological profile together with borderline ammonia levels suggest a mixture of minimal HE and cerebral damage of a different origin (prolonged alcohol misuse? Malnutrition-related encephalopathy?) in a patient with refractory ascites, malnutrition, sarcopenia.

15 Vignette - 24/09/ year old male Alcohol-related cirrhosis (off 3 yrs) Child C, MELD 20 Recovering from HE-related hospitalisation Two episodes of precipitated HE over the summer Fasting, venous ammonia 191 µmol/l (<35)

16 Vignette - 24/09/2014 Clinically normal Slow, blurred speech MMSE 23/30 16/30 PHES= Computer tests x CFF 38 x

17 Vignette May 2014 Sept 2014

18 Vignette - 29/05/2014..The current neuropsychiatric profile is compatible with overt HE, in a patient with additional risk factors for neuropsychiatric dysfunction (see May 2014 evaluation). It would be useful to discuss with family/carers preventable precipitants.

19 Cognitive dysfunction Clinically normal Slow, blurred speech MMSE 23/30 16/30 PHES= Computer tests x CFF 38 x

20 Hepatic Encephalopathy Clinically normal Slow, blurred speech MMSE 23/30 16/30 7 PHES= Computer tests x CFF 38 x

21 Cognitive dysfunction Clinically normal Slow, blurred speech MMSE 23/30 16/30 PHES=-10 (>-4) -12 Computer tests x CFF 38 (> 39 Hz) x

22 Cognitive dysfunction Clinically normal Slow, blurred speech MMSE 23/30 16/30 PHES=-10 (>-4) -12 Computer tests x CFF 38 (> 39 Hz) x

23 Reversibility TMTA DS LTt TMT-A * * * TMT-B DS SD LTT-t LTT-e Controls nohe prelt HE prelt * P<0.05 Sotil et al, Liver Transpl 2009

24 Predisposition / Co-morbidity Campagna et al, Liver Transpl 2014

25 Hepatic Encephalopathy...and What Else? 276 patients (58±11 yrs, Child A 37%, B 41%, C 22%) 99 (36%) neuropsychiatrically unimpaired 90 (33%) clinically obvious neuropsychiatric abnormalities (OHE) 87 (32%) PHES and/or EEG and/or CFF abnormalities (MHE) Montagnese et al. Hepatology, 2015

26 Hepatic Encephalopathy...and What Else? Of 90 OHE 55 (61%) had co-morbidities that could contribute/fully explain their neuropsychiatric profiles Of 87 MHE, 40 (46%) had co-morbidities that could contribute/fully explain their neuropsychiatric profiles 95/177 (54%)

27 Hepatic Encephalopathy...and What Else? Cerebrovascular disease (17) Recent alcohol misuse (15) Malnutrition (6) Infection/Sepsis (5) Psychoactive drugs (4) Severe hyponatremia, hypoglycemia, hypothyroidism (2 each) Other plus various combinations (42) These patients were older (59.8±10.8 vs. 56.8±11.5 yrs, p=0.04)

28 Hepatic Encephalopathy...and What Else? Montagnese et al. Hepatology, 2015

29 Hepatic Encephalopathy Substantially aspecific neurological and psychiatric symptoms/signs Attribution to liver failure and/or portalsystemic shunt

30 Hepatic Encephalopathy...and What Else? Montagnese et al. Hepatology, 2015

31 Hepatic Encephalopathy...and What Else? HE associated with ACLF occurs in younger cirrhotics with severe liver failure, in relation to bacterial infections, active alcoholism and/or dilutional hyponatremia. HE not associated with ACLF occurs in older cirrhotics, inactive drinkers, without severe liver failure or systemic inflammatory reaction, and in relation to diuretic use. Prognosis is extremely poor in the first and relatively preserved in the second group. Cordoba et al. J Hepatol 2014;60:

32 Comorbidity and Predisposition CIRRHOSIS OLTX CIRRHOSIS OLTX

33 Predisposition to Delirium Inouye et al, Lancet 2014

34 Reversibility and Predisposition CIRRHOSIS OLTX CIRRHOSIS OLTX

35 Hepatic Encephalopathy Caused associated by liver disease and/or shunt

36 Hepatic Encephalopathy Caused associated by liver disease Psychomotor slowing and decreased vigilance

37 Hepatic Encephalopathy Weissenbrn et al, Metabolic Brain Disease 2005

38 Sleepiness and HE Bersagliere et al., 2011

39 Hepatic Encephalopathy Caused associated by liver disease Psychomotor slowing and decreased vigilance Largely reversible

40 Hepatic Encephalopathy Caused associated by liver disease Psychomotor slowing and decreased vigilance Largely reversible Persistent HE Riggio O., Hepatology 2005

41 Hepatic Encephalopathy Caused associated by liver disease Psychomotor slowing and decreased vigilance Largely reversible Persistent HE Irreversible HE Riggio O., Hepatology 2005

42 Hepatic Encephalopathy Caused associated by liver disease Psychomotor slowing and decreased vigilance Largely reversible Persistent HE Irreversible HE Ammonia levels normal, diagnosis in question Should respond to ammonia-lowering treatment Sherlock S, Diseases of the Liver and Biliary System, 1955

43 Hepatic Encephalopathy Caused associated by liver disease Psychomotor slowing and decreased vigilance Largely reversible Persistent HE Irreversible HE Ammonia levels normal, diagnosis in question Should respond to ammonia-lowering treatment..and can therefore be removed from the picture! Sherlock S, Diseases of the Liver and Biliary System, 1955

44 Overt Hepatic Encephalopathy (Vilstrup et al, Hepatology, 2015)

45 Covert Hepatic Encephalopathy Relates to the degree of liver failure Relates to ammonia levels/inflammatory markers Test is more often abnormal in OHE Predicts OHE

46 Covert Hepatic Encephalopathy Relates to the degree of liver failure Relates to ammonia levels/inflammatory markers Test is more often abnormal in OHE Predicts OHE PHES, Scan test, Stroop test Critical Flicker Frequency Electroencephalogram

47 Differential Diagnosis INPATIENT OUTPATIENT Metabolic encephalopathy Drugs Malnutrition

48 Iron-deficiency Female HV 66 responders 47 non-responders Murray-Kolb & Beard Am J Clin Nutr 2007

49 Differential Diagnosis INPATIENT OUTPATIENT Metabolic encephalopathy Drugs Malnutrition Environment

50 Read and Finfer, NEJM 2014

51 Cognitive Impairment INPATIENT Metabolic encephalopathy Drugs Malnutrition Environment OUTPATIENT MCI/Dementia (Memory)

52 Syndrome Pathophysiology and DD

A Simplified Psychometric Evaluation for the Diagnosis of Minimal Hepatic Encephalopathy

A Simplified Psychometric Evaluation for the Diagnosis of Minimal Hepatic Encephalopathy CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2011;9:613 616 A Simplified Psychometric Evaluation for the Diagnosis of Minimal Hepatic Encephalopathy OLIVIERO RIGGIO,* LORENZO RIDOLA,* CHIARA PASQUALE,* ILARIA

More information

The Importance of Diagnosing Covert Hepatic Encephalopathy

The Importance of Diagnosing Covert Hepatic Encephalopathy The Importance of Diagnosing Covert Hepatic Encephalopathy Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council

More information

Treatment of Overt Hepatic Encephalopathy: Focus on Outpatient Management

Treatment of Overt Hepatic Encephalopathy: Focus on Outpatient Management Treatment of Overt Hepatic Encephalopathy: Focus on Outpatient Management Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation

More information

Thank you. for supporting this program. For additional CME offerings, please visit

Thank you. for supporting this program. For additional CME offerings, please visit Thank you for supporting this program For additional CME offerings, please visit www.chronicliverdisease.org Accredited by: Disease Burden Patient Discharges with Cirrhosis* Hospital Discharges Associated

More information

The Chronic Liver Disease Foundation (CLDF) and the International Coalition of Hepatology Education Providers (IC-HEP) present:

The Chronic Liver Disease Foundation (CLDF) and the International Coalition of Hepatology Education Providers (IC-HEP) present: The Chronic Liver Disease Foundation (CLDF) and the International Coalition of Hepatology Education Providers (IC-HEP) present: Certified by: Provided by: Endorsed by: Hepatic Encephalopathy Hepatic Encephalopathy:

More information

Cognitive Impairment and Electroencephalographic Alterations Before and After Liver Transplantation: What Is Reversible?

Cognitive Impairment and Electroencephalographic Alterations Before and After Liver Transplantation: What Is Reversible? LIVER TRANSPLANTATION 20:977 986, 2014 ORIGINAL ARTICLE Cognitive Impairment and Electroencephalographic Alterations Before and After Liver Transplantation: What Is Reversible? Francesca Campagna, 1 Sara

More information

Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate

Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate Patrick Northup, MD, FAASLD, FACG Medical Director, Liver Transplantation University of Virginia

More information

This educational website is funded by a grant from Norgine. Norgine has no responsibility for content or conduct of this website.

This educational website is funded by a grant from Norgine. Norgine has no responsibility for content or conduct of this website. Date of preparation: February 2014. 4C/NIPV/0517 1 This educational website is funded by a grant from Norgine. Norgine has no responsibility for content or conduct of this website. 2 Disclaimer This educational

More information

A Low-Cost, User-Friendly Electroencephalographic Recording System for the Assessment of Hepatic Encephalopathy

A Low-Cost, User-Friendly Electroencephalographic Recording System for the Assessment of Hepatic Encephalopathy AMERICAN ASSOCIATION FOR THE STUDY OFLIVERD I S E ASES HEPATOLOGY, VOL. 63, NO. 5, 2016 A Low-Cost, User-Friendly Electroencephalographic Recording System for the Assessment of Hepatic Encephalopathy Sami

More information

What s New in the Management of Hepatic Encephalopathy?

What s New in the Management of Hepatic Encephalopathy? What s New in the Management of Hepatic Encephalopathy? Jasmohan S Bajaj, MD Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond,

More information

Managing Encephalopathy in the Outpatient Setting

Managing Encephalopathy in the Outpatient Setting REVIEW Managing Encephalopathy in the Outpatient Setting Sahaj Rathi, M.D., and Radha K. Dhiman, M.D., D.M., F.A.M.S., F.A.C.G., F.R.C.P., F.A.A.S.L.D. Hepatic encephalopathy (HE) refers to brain dysfunction

More information

Electroencephalography Versus Psychometric Tests in Diagnosis of Minimal Hepatic Encephalopathy

Electroencephalography Versus Psychometric Tests in Diagnosis of Minimal Hepatic Encephalopathy Elmer ress Original Article J Neurol Res. 2016;6(4):65-71 Electroencephalography Versus Psychometric Tests in Diagnosis of Minimal Hepatic Encephalopathy Aktham Ismail Alemam a, b, Mohamed Ahmad Shaaban

More information

NIH Public Access Author Manuscript Aliment Pharmacol Ther. Author manuscript; available in PMC 2014 April 01.

NIH Public Access Author Manuscript Aliment Pharmacol Ther. Author manuscript; available in PMC 2014 April 01. NIH Public Access Author Manuscript Published in final edited form as: Aliment Pharmacol Ther. 2011 April ; 33(7): 739 747. doi:10.1111/j.1365-2036.2011.04590.x. Review article: the design of clinical

More information

Hepatic Encephalopathy Update:

Hepatic Encephalopathy Update: Hepatic Encephalopathy Update: Reports From the American Association for the Study of Liver Diseases Annual Meeting, 2011 Project ID: 11-0014-NL-4 Credit Designation Hepatic encephalopathy (HE) is a largely

More information

JMSCR Vol 05 Issue 11 Page November 2017

JMSCR Vol 05 Issue 11 Page November 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 71.58 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i11.33 Prevalence of Hyponatremia among patients

More information

Program Disclosure. A maximum of 1.5 contact hours may be earned for successful completion of this activity.

Program Disclosure. A maximum of 1.5 contact hours may be earned for successful completion of this activity. Program Disclosure This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through

More information

Management of overt hepatic encephalopathy: a focus on rifaximin-α and NICE TA337

Management of overt hepatic encephalopathy: a focus on rifaximin-α and NICE TA337 cpd credits summarising clinical guidelines for primary care Guidance Update www. Management of overt hepatic encephalopathy: a focus on rifaximin-α and NICE TA337 This Guidelines supplement has been commissioned

More information

The Egyptian Journal of Hospital Medicine (October 2018) Vol. 73 (4), Page

The Egyptian Journal of Hospital Medicine (October 2018) Vol. 73 (4), Page The Egyptian Journal of Hospital Medicine (October 2018) Vol. 73 (4), Page 6541-6554 Diagnosis of Minimal Hepatic Encephalopathy of Cirrhotic Patients Using a Combination of Neuropsychiatric and Neurophysiological

More information

Hepatic encephalopathy (HE) is a frequent and severe. Improving the Inhibitory Control Task to Detect Minimal Hepatic Encephalopathy

Hepatic encephalopathy (HE) is a frequent and severe. Improving the Inhibitory Control Task to Detect Minimal Hepatic Encephalopathy GASTROENTEROLOGY 2010;139:510 518 Improving the Inhibitory Control Task to Detect Minimal Hepatic Encephalopathy PIERO AMODIO,* LORENZO RIDOLA, SAMI SCHIFF,*, SARA MONTAGNESE,* CHIARA PASQUALE, SILVIA

More information

Rita Garcia Martinez Juan Rodés Grupo investigación enfermedades hepáticas y digestivas Hospital General Universitario Gregorio Marañon

Rita Garcia Martinez Juan Rodés Grupo investigación enfermedades hepáticas y digestivas Hospital General Universitario Gregorio Marañon Rita Garcia Martinez Juan Rodés Grupo investigación enfermedades hepáticas y digestivas Hospital General Universitario Gregorio Marañon Medico especialista Medicina Interna-Hepatología H. Vall d Hebron

More information

The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies

The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies INVITED REVIEW Annals of Gastroenterology (2018) 31, 1-14 The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies Lorenzo Ridola a, Vincenzo Cardinale a, Oliviero Riggio

More information

Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis

Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis Turk J Gastroenterol 2017; 28: 191-6 Liver Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis Banu Demet Özel Coşkun 1, Mustafa Özen 2 1 Clinic of

More information

Hepatic Encephalopathy Update: Reports from the 2013 International Liver Conference

Hepatic Encephalopathy Update: Reports from the 2013 International Liver Conference Reports from the 2013 International Liver Conference Credit Designation Purdue University College of Pharmacy designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians

More information

Analysis of combined effect of synbiotic and LOLA in improving neuropsychometric function

Analysis of combined effect of synbiotic and LOLA in improving neuropsychometric function 2017; 6(5): 152-156 ISSN (E): 2277-7695 ISSN (P): 2349-8242 NAAS Rating 2017: 5.03 TPI 2017; 6(5): 152-156 2017 TPI www.thepharmajournal.com Received: 26-03-2017 Accepted: 27-04-2017 Preetha Nandabalan

More information

Transjugular intrahepatic portosystemic shunts

Transjugular intrahepatic portosystemic shunts Pre-Transjugular Intrahepatic Portosystemic Shunts (TIPS) Prediction of Post-TIPS Overt Hepatic Encephalopathy: The Critical Flicker Frequency Is More Accurate Than Psychometric Tests Pierre Berlioux,

More information

Management of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy

Management of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy Management of Ascites and Hepatorenal Syndrome Florence Wong University of Toronto June 4, 2016 6/16/2016 1 Disclosures Gore & Associates: Consultancy Sequana Medical: Research Funding Mallinckrodt Pharmaceutical:

More information

Management of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University

Management of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University Management of Cirrhotic Complications Uncontrolled Ascites Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University Topic Definition, pathogenesis Current therapeutic options Experimental treatments

More information

Luis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Louisville and Louisville VAMC 2015

Luis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Louisville and Louisville VAMC 2015 Luis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Louisville and Louisville VAMC 2015 Protein-calorie malnutrition (PCM) is extremely common

More information

Normalization of the Psychometric Hepatic Encephalopathy score for Diagnosis of Minimal Hepatic Encephalopathy in Turkey

Normalization of the Psychometric Hepatic Encephalopathy score for Diagnosis of Minimal Hepatic Encephalopathy in Turkey Original Article Normalization of the Psychometric Hepatic Encephalopathy score for Diagnosis of Minimal Hepatic Encephalopathy in Turkey BDO Coskun, M Ozen 1, S Gursoy 2, O Ozbakir 2, OK Poyrazoglu, M

More information

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES International Journal of Institutional Pharmacy and Life Sciences 5(5): September-October 2015 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Life Sciences Research Article!!! Received:

More information

Hepatic Encephalopathy A 2016 perspective Rajiv Jalan UCL Institute for Liver and Digestive Health Royal Free Hospital

Hepatic Encephalopathy A 2016 perspective Rajiv Jalan UCL Institute for Liver and Digestive Health Royal Free Hospital Malaga 2016 Hepatic Encephalopathy A 2016 perspective Rajiv Jalan UCL Institute for Liver and Digestive Health Royal Free Hospital Disclosures (Rajiv Jalan): Inventor: Ornithine phenyl acetate for the

More information

Management of Cirrhosis Related Complications

Management of Cirrhosis Related Complications Management of Cirrhosis Related Complications Ke-Qin Hu, MD, FAASLD Professor of Clinical Medicine Director of Hepatology University of California, Irvine Disclosure I have no disclosure related to this

More information

Hepatic encephalopathy: Diagnosis and management

Hepatic encephalopathy: Diagnosis and management Received: 26 February 2018 Accepted: 28 March 2018 DOI: 10.1111/liv.13752 REVIEW Hepatic encephalopathy: Diagnosis and management Piero Amodio Department of Medicine -DIMED- and CIRMANMEC, University of

More information

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Ascites Management Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH have no relevant

More information

Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL

Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL Terminology Acute decompensation of cirrhosis - stable patient with sudden deterioration Acute-on-chronic liver failure

More information

Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases

Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases Credit Designation Purdue University College of Pharmacy designates this

More information

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT Sherona Bau, ACNP The Pfleger Liver Institute 200 UCLA Medical Plaza, Suite 214 Los Angeles, CA 90095 September 30, 2017 I

More information

Causes of Liver Disease in US

Causes of Liver Disease in US Learning Objectives Updates in Outpatient Cirrhosis Management Jennifer Guy, MD MAS Director, Liver Cancer Program California Pacific Medical Center guyj@sutterhealth.org Review cirrhosis epidemiology,

More information

HEPATIC ENCEPHALOPATHY(HE) AND NUTRITIONAL SUPPORT. Jin-Woo Lee, MD,PhD. Division of Hepatology Inha University Hospital

HEPATIC ENCEPHALOPATHY(HE) AND NUTRITIONAL SUPPORT. Jin-Woo Lee, MD,PhD. Division of Hepatology Inha University Hospital HEPATIC ENCEPHALOPATHY(HE) AND NUTRITIONAL SUPPORT Jin-Woo Lee, MD,PhD. Division of Hepatology Inha University Hospital Contents 1. Definition and causes of HE 2. Diagnosis and treatment of HE 3. Malnutriton

More information

Hyponatremia and Zinc deficiency as a risk factor for Hepatic Encephalopathy in Cirrhotic Patients.

Hyponatremia and Zinc deficiency as a risk factor for Hepatic Encephalopathy in Cirrhotic Patients. Hyponatremia and Zinc deficiency as a risk factor for Hepatic Encephalopathy in Cirrhotic Patients 1 Mohsen Maher, 1 Tarek M. Yosef, 2 Amal I.Sabry, 1 Shereen A. Saleh and 2 H. Alkady 1 Internal Medicine

More information

Biology of Hepatic Encephalopathy. School of Medicine Division of Transplantation Immunology & Mucosal Biology MRC Centre for Transplantation

Biology of Hepatic Encephalopathy. School of Medicine Division of Transplantation Immunology & Mucosal Biology MRC Centre for Transplantation Biology of Hepatic Encephalopathy School of Medicine Division of Transplantation Immunology & Mucosal Biology MRC Centre for Transplantation Pavlov s Physiology Factory 1904: Nobel Prize for developing

More information

Hepatology on the AMU

Hepatology on the AMU Hepatology on the AMU RCP day, 8 th February 2018 Jo Leithead Consultant in Hepatology and Liver Transplantation Addenbrookes Hospital Cambridge Is liver disease relevant to me? Williams R, Lancet 2014

More information

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals By: Dr. Kevin Dolehide Overview DX Cirrhosis and Prognosis Compensated Decompensated Complications Of Cirrhosis Management Of Complications

More information

Cirrhosis and chronic liver disease adversely affect

Cirrhosis and chronic liver disease adversely affect Spectrum of Neurocognitive Impairment in Cirrhosis: Implications for the Assessment of Hepatic Encephalopathy Jasmohan S. Bajaj, 1 James B. Wade, 2 and Arun J. Sanyal 1 Abbreviations: BDT, Block Design

More information

Management of Hepatic Encephalopathy

Management of Hepatic Encephalopathy Management of Hepatic Encephalopathy Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH

More information

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed?

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed? CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed? The Hospitalist. 2016 August;2016(8) Author(s): Raj Sehgal, MD; Joshua Hanson, MD, MPH; Division OF The

More information

A Head CT is Unnecessary in the Initial Evaluation of A Cirrhotic Patient with Recurrent Hepatic Encephalopathy

A Head CT is Unnecessary in the Initial Evaluation of A Cirrhotic Patient with Recurrent Hepatic Encephalopathy 810 ORIGINAL ARTICLE September-October, Vol. 17 No. 5, 2018: 810-814 The Official Journal of the Mexican Association of Hepatology, the Latin-American Association for Study of the Liver and the Canadian

More information

Program Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals.

Program Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals. Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship

More information

Case Report Low-Dose Tolvaptan for the Treatment of Dilutional Hyponatremia in Cirrhosis: A Case Report and Literature Review

Case Report Low-Dose Tolvaptan for the Treatment of Dilutional Hyponatremia in Cirrhosis: A Case Report and Literature Review Case Reports in Hepatology, Article ID 795261, 4 pages http://dx.doi.org/10.1155/2014/795261 Case Report Low-Dose Tolvaptan for the Treatment of Dilutional Hyponatremia in Cirrhosis: A Case Report and

More information

Nutrition Management of End- Stage Liver Failure

Nutrition Management of End- Stage Liver Failure Nutrition Management of End- Stage Liver Failure Krystel Ouaijan, RDN, MSc Nutrition Support Dietitian in Saint George Hospital UMC PhD in University of Geneva Just few questions https://www.mentimeter.com/s/c1c1be18dc2

More information

Update in abdominal Surgery in cirrhotic patients

Update in abdominal Surgery in cirrhotic patients Update in abdominal Surgery in cirrhotic patients Safi Dokmak HBP department and liver transplantation Beaujon Hospital, Clichy, France Cairo, 5 April 2016 Cirrhosis Prevalence in France (1%)* Patients

More information

Complex neuropsychatric syndrome complicating advanced liver disease and/or portosystemic shunting (1990s) Complex neuropsychatric syndrome caused by

Complex neuropsychatric syndrome complicating advanced liver disease and/or portosystemic shunting (1990s) Complex neuropsychatric syndrome caused by Complex neuropsychatric syndrome complicating advanced liver disease and/or portosystemic shunting (1990s) Complex neuropsychatric syndrome caused by portosystemic venous shunting with or without intrinsic

More information

Hepatorenal Syndrome

Hepatorenal Syndrome Necker Seminars in Nephrology Institut Pasteur Paris, April 22, 2013 Hepatorenal Syndrome Dr. Richard Moreau 1 INSERM U773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3, 2 Université Paris Diderot

More information

following the last documented transfusion; thereafter, evaluate the residual impairment(s).

following the last documented transfusion; thereafter, evaluate the residual impairment(s). Adult Listings 5.01 Category of Impairments, Digestive System 5.02 Gastrointestinal hemorrhaging from any cause, requiring blood transfusion (with or without hospitalization) of at least 2 units of blood

More information

Minimal Hepatic Encephalopathy

Minimal Hepatic Encephalopathy Review articles Crhistian Camilo Gómez D., 1 Juan Carlos Restrepo G., MD 2 1 Medical Student at the University of Antioquia in Medellín, Colombia 2 Unit of Hepatology and Liver Transplant Program of the

More information

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for: Contraindications Absolute Relative Primary prevention variceal bleeding HCC if centrally located Active congestive heart failure Obstruction all hepatic veins Thomas D. Boyer, M.D. University of Arizona

More information

MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy

MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy Martel-Laferrière et al. BMC Gastroenterology 2014, 14:185 RESEARCH ARTICLE Open Access MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy

More information

Cuban Normality Tables for Psychometric Tests Used for Diagnosis of Minimal Hepatic Encephalopathy

Cuban Normality Tables for Psychometric Tests Used for Diagnosis of Minimal Hepatic Encephalopathy Original articles Cuban Normality Tables for Psychometric Tests Used for Diagnosis of Minimal Hepatic Encephalopathy Maykel Alain Padilla Ruiz, MD, MSc 1 1 First Degree Specialist in Gastroenterology,

More information

The Management of Ascites & Hepatorenal Syndrome. Florence Wong University of Toronto. Falk Symposium March 14, 2008

The Management of Ascites & Hepatorenal Syndrome. Florence Wong University of Toronto. Falk Symposium March 14, 2008 The Management of Ascites & Hepatorenal Syndrome Florence Wong University of Toronto Falk Symposium March 14, 2008 Management of Ascites Sodium Restriction Mandatory at all stages of ascites in order to

More information

Conflict of interest disclosures. Complications of end stage liver disease. None. The many complications of Cirrhosis. Portal Hypertension.

Conflict of interest disclosures. Complications of end stage liver disease. None. The many complications of Cirrhosis. Portal Hypertension. Complications of end stage liver disease Conflict of interest disclosures None Amir Qamar, MD Instructor of Medicine Brigham and Women s s Hospital Harvard Medical School Boston, MA 02115 The many complications

More information

Care of the Patient With Cirrhosis

Care of the Patient With Cirrhosis REVIEW Care of the Patient With Cirrhosis Anitha Yadav, M.D., and Hugo E. Vargas, M.D. Caring for patients with cirrhosis involves multidisciplinary and timely management of several complications while

More information

King s College Hospital NHS Foundation Trust. Acute on Chronic Liver Failure: Practical management outside the tertiary centre.

King s College Hospital NHS Foundation Trust. Acute on Chronic Liver Failure: Practical management outside the tertiary centre. King s College Hospital NHS Foundation Trust NHS Acute on Chronic Liver Failure: Practical management outside the tertiary centre. William Bernal Professor of Liver Critical Care Liver Intensive Therapy

More information

Acute Liver Failure. Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018

Acute Liver Failure. Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018 Acute Liver Failure Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018 Disclosures None Outline Overview of ALF Management of ALF Diagnosis of ALF Treatments and Support

More information

Management of the Cirrhotic Patient in the ICU

Management of the Cirrhotic Patient in the ICU Management of the Cirrhotic Patient in the ICU Peter E. Morris, MD Professor & Chief, Pulmonary, Critical Care and Sleep Medicine University of Kentucky Conflict of Interest Funding US National Institutes

More information

The relationship between portal-systemic shunts

The relationship between portal-systemic shunts LIVER FAILURE AND LIVER DISEASE LIVER FAILURE High Prevalence of Spontaneous Portal-Systemic Shunts in Persistent Hepatic Encephalopathy: A Case-Control Study Oliviero Riggio, 1 Cesare Efrati, 1 Carlo

More information

PALLIATIVE CARE IN END-STAGE LIVER DISEASE

PALLIATIVE CARE IN END-STAGE LIVER DISEASE PALLIATIVE CARE IN END-STAGE LIVER DISEASE Ken S. Ota, DO Family Medicine Banner Good Samaritan Medical Center Learning Objectives: Describe the common bio-psycho-social issues in end-stage liver disease

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Accelerated intravascular coagulation and fibrinolysis (AICF) in liver disease, 390 391 Acid suppression in liver disease, 403 404 ACLF.

More information

The usefulness of critical flicker frequency in the diagnosis and follow-up of covert hepatic encephalopathy treated with Rifaximin-α

The usefulness of critical flicker frequency in the diagnosis and follow-up of covert hepatic encephalopathy treated with Rifaximin-α Human & Veterinary Medicine International Journal of the Bioflux Society OPEN ACCESS Research Article The usefulness of critical flicker frequency in the diagnosis and follow-up of covert hepatic encephalopathy

More information

Initial approach to ascites

Initial approach to ascites Ascites: Filling and Draining the Water Balloon Common Pathogenesis in Refractory Ascites, Hyponatremia, and Cirrhosis intrahepatic resistance sinusoidal portal hypertension Splanchnic vasodilation (effective

More information

Organ allocation for liver transplantation: Is MELD the answer? North American experience

Organ allocation for liver transplantation: Is MELD the answer? North American experience Organ allocation for liver transplantation: Is MELD the answer? North American experience Douglas M. Heuman, MD Virginia Commonwealth University Richmond, VA, USA March 1998: US Department of Health and

More information

Denver Shunts vs TIPS for Ascites

Denver Shunts vs TIPS for Ascites Denver Shunts vs TIPS for Ascites Hooman Yarmohammadi MD Assistant Professor of Radiology Interventional Radiology & Image Guided Therapies Memorial Sloan-Kettering Cancer Center, New York, USA Hooman

More information

Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis

Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis Sponsored by Integrity Continuing Education, Inc. Supported by an educational Practitioner

More information

Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study

Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study Koziarska et al. BMC Gastroenterology 2013, 13:107 RESEARCH ARTICLE Open Access Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography

More information

Hepatic encephalopathy (HE) is a neuropsychiatric

Hepatic encephalopathy (HE) is a neuropsychiatric Considerations for the Cost-Effective Management of Hepatic Encephalopathy Steven L. Flamm, MD Hepatic encephalopathy (HE) is a neuropsychiatric condition that is usually associated with acute or chronic

More information

Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC

Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC mino.mitri@ubc.ca No Conflict of Interest 157 patients 157 patients 6 transplanted Criteria Liver

More information

Filippo Schepis, MD Università degli Studi di Modena e Reggio Emilia

Filippo Schepis, MD Università degli Studi di Modena e Reggio Emilia Filippo Schepis, MD Università degli Studi di Modena e Reggio Emilia Il sottoscritto dichiara di non aver avuto/di aver avuto negli ultimi 12 mesi conflitto d interesse in relazione a questa presentazione

More information

Embolization of Portosystemic Shunts for Treatment of Medically Refractory Hepatic Encephalopathy

Embolization of Portosystemic Shunts for Treatment of Medically Refractory Hepatic Encephalopathy ORIGINAL ARTICLE Embolization of Portosystemic Shunts for Treatment of Medically Refractory Hepatic Encephalopathy Amanda M. Lynn, 1 Siddharth Singh, 4 Stephen E. Congly, 5 Disha Khemani, 2 David H. Johnson,

More information

Electrophysiologic approaches to delirium. Overview

Electrophysiologic approaches to delirium. Overview Electrophysiologic approaches to delirium Alvaro Pascual Leone, MD, PhD Mouhsin Shafi, MD, PhD Overview Overview of the problem and techniques Electrophysiological studies in delirium Electrophysiological

More information

Infections In Cirrhotic patients. Dr Abid Suddle Institute of Liver Studies King s College Hospital

Infections In Cirrhotic patients. Dr Abid Suddle Institute of Liver Studies King s College Hospital Infections In Cirrhotic patients Dr Abid Suddle Institute of Liver Studies King s College Hospital Infection in cirrhotic patients Leading cause morbidity/mortality Common: 30-40% of hospitalised cirrhotic

More information

Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy

Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy BIOMEDICAL REPORTS 5: 193-198, 2016 Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy EMI YOSHIMURA 1,

More information

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Cagliari, 16 settembre 2017 CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Vincenza Calvaruso, MD, PhD Ricercatore di Gastroenterologia Gastroenterologia & Epatologia, Di.Bi.M.I.S. Università degli Studi di

More information

National Institute for Health and Clinical Excellence. Single Technology Appraisal (STA)

National Institute for Health and Clinical Excellence. Single Technology Appraisal (STA) Comment 2: the draft scope Appendix D NICE s response to consultee and commentator comments on the draft scope and provisional matrix National Institute for Health and Clinical Excellence Single Technology

More information

Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis

Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis Sponsored by Integrity Continuing Education, Inc. Supported by an educational Practitioner

More information

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:1187 1191 EDUCATION PRACTICE Management of Refractory Ascites ANDRÉS CÁRDENAS and PERE GINÈS Liver Unit, Institute of Digestive Diseases, Hospital Clínic,

More information

Faculty Disclosure. Objectives. Cirrhosis Management for the Family Physician 18/11/2014

Faculty Disclosure. Objectives. Cirrhosis Management for the Family Physician 18/11/2014 Cirrhosis Management for the Family Physician Mang Ma, MD, FRCP Professor University of Alberta Faculty: Mang Ma Faculty Disclosure Relationships with commercial interests: Advisory Board: Merck, Gilead

More information

Rendu Osler Weber disease or Hereditary Hemorrhagic Telangiectasia (HHT): liver vascular involvement

Rendu Osler Weber disease or Hereditary Hemorrhagic Telangiectasia (HHT): liver vascular involvement Rendu Osler Weber disease or Hereditary Hemorrhagic Telangiectasia (HHT): liver vascular involvement Elisabetta Buscarini Gastroenterology Dept European Reference Center for HHT ASST Ospedale Maggiore

More information

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust The Yellow Patient Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust there s a yellow patient in bed 40. It s one of yours. Liver Cirrhosis Why.When.What.etc.

More information

ESPEN Congress Madrid 2018

ESPEN Congress Madrid 2018 ESPEN Congress Madrid 2018 Nutrition In Solid Organ Transplant Patients Undernutrition In Transplant Patients O. Abbasoglu (TR) Undernutrition in Transplant Patients Dr. Osman Abbasoğlu Professor of Surgery,

More information

Child Neurology Elective PL1 Rotation

Child Neurology Elective PL1 Rotation PL1 Rotation The neurology elective is available to first year residents in either a 2 or 4 week block rotation. The experience will include performing inpatient consultations, attending outpatient clinics

More information

This survey aims to look at individual practice and can be completed by any healthcare professional.

This survey aims to look at individual practice and can be completed by any healthcare professional. This survey aims to look at individual practice and can be completed by any healthcare professional. If you have any questions about how this form should be completed please contact Dr Grace Ting (ghlting@doctors.net.uk)

More information

Managing Encephalopathy in the Outpatient Setting

Managing Encephalopathy in the Outpatient Setting Tarana Gupta et al MINI REVIEW 10.5005/jp-journals-10018-1211 1 Tarana Gupta, 2 Sahaj Rathi, 2 Radha K Dhiman 1 Department of Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,

More information

Interventions to improve physical function and prevent adverse events in cirrhosis

Interventions to improve physical function and prevent adverse events in cirrhosis Gastroenterology Report, 6(1), 2018, 13 20 doi: 10.1093/gastro/gox042 Advance Access Publication Date: 10 January 2018 Review REVIEW Interventions to improve physical function and prevent adverse events

More information

Hepatorenal syndrome. Jan T. Kielstein Departent of Nephrology Medical School Hannover

Hepatorenal syndrome. Jan T. Kielstein Departent of Nephrology Medical School Hannover Hepatorenal syndrome Jan T. Kielstein Departent of Nephrology Medical School Hannover Hepatorenal Syndrome 1) History of HRS 2) Pathophysiology of HRS 3) Definition of HRS 4) Clinical presentation of HRS

More information

Prevalence of minimal hepatic encephalopathy in cirrhotic patients

Prevalence of minimal hepatic encephalopathy in cirrhotic patients S40 MODULE? Vol. 10 Suppl.2, 2011: S40-S44 Prevalence of minimal hepatic encephalopathy in cirrhotic patients Héctor Jesús Maldonado-Garza,* Genaro Vázquez-Elizondo,* Juan Obed Gaytán-Torres,* Ángel Ricardo

More information

Ontario s Adult Referral and Listing Criteria for Liver Transplantation

Ontario s Adult Referral and Listing Criteria for Liver Transplantation Ontario s Adult Referral and Listing Criteria for Liver Transplantation Version 3.0 Trillium Gift of Life Network Ontario s Adult Referral & Listing Criteria for Liver Transplantation PATIENT REFERRAL

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,100 116,000 120M Open access books available International authors and editors Downloads Our

More information

Associate Professor,Department Of Radiology, Malda Medical College, Malda. Corresponding author: *Dr.Gauranga Biswas

Associate Professor,Department Of Radiology, Malda Medical College, Malda. Corresponding author: *Dr.Gauranga Biswas IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 7 Ver. II (July. 2017), PP 50-54 www.iosrjournals.org A Comparative Study to Determine the

More information

Minimal and overt hepatic encephalopathy are constituents

Minimal and overt hepatic encephalopathy are constituents GASTROENTEROLOGY 2010;138:2332 2340 Persistence of Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy JASMOHAN S. BAJAJ,*, CHRISTINE M. SCHUBERT, DOUGLAS M. HEUMAN,* JAMES B. WADE, DOUGLAS

More information

ACUTE-ON-CHRONIC LIVER FAILURE: DEFINITION, DIAGNOSIS AND CLINICAL CHARACTERISTICS.

ACUTE-ON-CHRONIC LIVER FAILURE: DEFINITION, DIAGNOSIS AND CLINICAL CHARACTERISTICS. ACUTE-ON-CHRONIC LIVER FAILURE: DEFINITION, DIAGNOSIS AND CLINICAL CHARACTERISTICS. Vicente Arroyo 1, 2, Rajiv Jalan 2, 3 1 Institut de Investigacions Biomèdiques August Pi I Sunyer. University of Barcelona.

More information

Faculty Affiliation. Faculty Disclosures. Alpesh Amin, MD, has no real or apparent conflicts of interest to report.

Faculty Affiliation. Faculty Disclosures. Alpesh Amin, MD, has no real or apparent conflicts of interest to report. Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis Sponsored by Integrity Continuing Education, Inc. Supported by an educational Practitioner

More information